Patent details
EP3449921 Title: ERIBULIN FOR INHIBITING TUMOR GROWTH
Basic Information
- Publication number:
- EP3449921
- PCT Application Number:
- JP2017016633
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP177896321
- PCT Publication Number:
- WO2017188350
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ERIBULIN FOR INHIBITING TUMOR GROWTH
- French Title of Invention:
- ERIBULIN POUR L' INHIBITION DE CROISSANCE TUMORALE
- German Title of Invention:
- ERIBULIN ZUR HEMMUNG DES TUMORWACHSTUMS
- SPC Number:
Dates
- Filing date:
- 26/04/2017
- Grant date:
- 31/05/2023
- EP Publication Date:
- 06/03/2019
- PCT Publication Date:
- 02/11/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 31/05/2023
- EP B1 Publication Date:
- 31/05/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/04/2024
- Expiration date:
- 26/04/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/05/2023
- Name:
- Eisai R&D Management Co., Ltd.
- Address:
- 4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, Japan (JP)
Inventor
1
- Name:
- ASANO, Makoto
- Address:
- Japan (JP)
2
- Name:
- MATSUI, Junji
- Address:
- Japan (JP)
Priority
- Priority Number:
- 2016091919
- Priority Date:
- 28/04/2016
- Priority Country:
- Japan (JP)
Classification
- IPC classification:
- A61K 31/357; A61K 9/127; A61P 35/00; A61P 43/00;
Publication
European Patent Bulletin
- Issue number:
- 202322
- Publication date:
- 31/05/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|